The role of post-operative radiotherapy in non-small-cell lung cancer: a multicentre randomised trial in patients with pathologically staged T1-2 N1j2, Mo disease
1996

Post-operative Radiotherapy in Non-Small-Cell Lung Cancer

Sample size: 308 publication Evidence: moderate

Author Information

Author(s): RJ Stephens, DJ Girling, NM Bleehen, K Moghissi, HMA Yosef, D Machin

Primary Institution: MRC Cancer Trials Office

Hypothesis

Does post-operative radiotherapy improve survival in patients with non-small-cell lung cancer?

Conclusion

The study found no clear advantage to post-operative radiotherapy in terms of survival for patients with N1 disease, but it may reduce local recurrence and metastases in N2 disease.

Supporting Evidence

  • 308 patients were enrolled from 16 centers in the UK.
  • Patients were randomly assigned to receive either surgery alone or surgery plus radiotherapy.
  • The study found no significant difference in overall survival between the two treatment groups.

Takeaway

Doctors wanted to see if giving radiation after surgery helps lung cancer patients live longer. They found it didn't help some patients, but it might help others.

Methodology

The study was a multicentre randomised trial comparing surgery alone with surgery plus post-operative radiotherapy in patients with pathologically staged T1-2, N1-2, M0 non-small-cell lung cancer.

Potential Biases

Potential biases may arise from the randomization process and the selection of patients based on preoperative staging.

Limitations

The trial's results may not be generalizable due to the specific patient population and treatment protocols used.

Participant Demographics

Median age was 62 years, 74% were male, and 68% had squamous carcinoma.

Statistical Information

P-Value

0.99

Confidence Interval

95% CI 0.77-1.30

Statistical Significance

p=0.99

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication